Subscribe to our newsletter to receive the latest product updates and special offers

HomeNewsScreenerMapsGroupsPortfolioInsiderFuturesForexCryptoBacktestsElite
Theme 		Help

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Earnings

Review historical estimates and see whether a company has beaten or missed expectations.

LBPH

Longboard Pharmaceuticals Inc

Last Close
Jun 14 • 04:00PM ET
18.52
Dollar change
-1.43
Percentage change
-7.17 		%
Held by: VTI IWM VXF IWN XPH VTWO IWO IWC ESML VFMO Scroll to Statements
IndexRUT P/E- EPS (ttm)-2.26 Insider Own15.48% Shs Outstand38.88M Perf Week5.53%
Market Cap720.06M Forward P/E- EPS next Y-2.28 Insider Trans-39.80% Shs Float32.86M Perf Month-12.39%
Income-57.95M PEG- EPS next Q-0.44 Inst Own96.64% Short Float11.95% Perf Quarter-4.14%
Sales0.00M P/S- EPS this Y23.95% Inst Trans-1.37% Short Ratio10.40 Perf Half Y292.37%
Book/sh8.07 P/B2.30 EPS next Y-25.25% ROA-28.45% Short Interest3.93M Perf Year149.26%
Cash/sh8.26 P/C2.24 EPS next 5Y- ROE-30.04% 52W Range3.60 - 28.15 Perf YTD207.13%
Dividend Est.- P/FCF- EPS past 5Y- ROI-18.26% 52W High-34.21% Beta1.16
Dividend TTM- Quick Ratio31.43 Sales past 5Y0.00% Gross Margin- 52W Low414.44% ATR (14)1.38
Dividend Ex-Date- Current Ratio31.43 EPS Y/Y TTM11.92% Oper. Margin0.00% RSI (14)46.19 Volatility10.38% 7.01%
Employees50 Debt/Eq0.01 Sales Y/Y TTM- Profit Margin- Recom1.12 Target Price43.75
Option/ShortYes / Yes LT Debt/Eq0.01 EPS Q/Q24.41% Payout- Rel Volume1.22 Prev Close19.95
Sales Surprise- EPS Surprise14.41% Sales Q/Q- EarningsMay 02 AMC Avg Volume377.62K Price18.52
SMA20-2.62% SMA50-5.00% SMA20031.68% Trades Volume460,317 Change-7.17%
Date Action Analyst Rating Change Price Target Change
May-01-24Initiated Robert W. Baird Outperform $36
Feb-16-24Initiated Citigroup Buy $40
Oct-24-23Resumed Cantor Fitzgerald Overweight $16 → $35
Apr-27-23Initiated B. Riley Securities Buy $13
Apr-07-21Initiated Evercore ISI Outperform $35
Apr-06-21Initiated Guggenheim Buy $27
Apr-06-21Initiated Citigroup Buy $37
Apr-06-21Initiated Cantor Fitzgerald Overweight $32
Jun-10-24 09:00AM
Longboard Pharmaceuticals Announces Positive Interim Results from the Open-Label Extension (OLE) of the Phase 1b/2a PACIFIC Study Evaluating Bexicaserin in Participants with Developmental and Epileptic Encephalopathies (DEEs)
(Business Wire)
Jun-03-24 04:01PM
Longboard Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
(Business Wire)
May-06-24 04:01PM
Longboard Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
(Business Wire)
May-04-24 05:31AM
Longboard Pharmaceuticals Inc. (LBPH) Q1 2024 Earnings: Financial and Strategic Developments
(GuruFocus.com)
May-03-24 10:10AM
Wedbush Adjusts Longboard Pharmaceuticals' PT to $34 From $32, Keeps Outperform Rating
(MT Newswires) -6.29%
09:58PM Loading…
May-02-24 09:58PM
LBPH Stock Earnings: Longboard Pharmaceuticals Beats EPS for Q1 2024
(InvestorPlace)
04:01PM
Longboard Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Corporate Updates
(Business Wire)
May-01-24 09:49AM
Starbucks downgraded, Dollar Tree upgraded: Wall Street's top analyst calls
(The Fly)
07:07AM
Baird Starts Longboard Pharmaceuticals With Outperform Rating, $36 Price Target
(MT Newswires)
Apr-03-24 09:00AM
Longboard Pharmaceuticals to Present Late-Breaking Data from the PACIFIC Study at the American Academy of Neurology (AAN) Annual Meeting on April 15
(Business Wire) -8.39%
Apr-02-24 04:00PM
Longboard Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
(Business Wire) -6.03%
Mar-14-24 05:31AM
Longboard Pharmaceuticals Inc Reports Full Year 2023 Financial Results
(GuruFocus.com) -5.36%
Mar-12-24 04:01PM
Longboard Pharmaceuticals Reports Full Year 2023 Financial Results and Provides Corporate Updates
(Business Wire)
Mar-01-24 04:01PM
Longboard Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
(Business Wire)
Feb-02-24 04:30PM
Longboard Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
(Business Wire) -6.34%
08:30AM Loading…
Feb-01-24 08:30AM
Longboard Pharmaceuticals to Present at Two Upcoming Investor Conferences in February
(Business Wire)
Jan-17-24 05:51AM
Forget the "Magnificent Seven" -- This Stock Has Nearly Quadrupled in 2024, and Wall Street Thinks It Can Go a Lot Higher
(Motley Fool)
Jan-08-24 04:05PM
Longboard Pharmaceuticals Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters Option to Purchase Additional Shares
(Business Wire)
Jan-05-24 08:50AM
Recent Price Trend in Longboard Pharmaceuticals, Inc. (LBPH) is Your Friend, Here's Why
(Zacks)
Jan-03-24 09:40PM
Longboard Pharmaceuticals Announces Pricing of Upsized Public Offering of Common Stock
(Business Wire) -10.76%
09:19AM
Longboard Pharma (LBPH) Up on Upbeat Data From Epilepsy Study
(Zacks)
Jan-02-24 04:37PM
Why Longboard Pharma Catapulted 316%, Leading A Biotech Stock Rally
(Investor's Business Daily) +316.25%
04:01PM
Longboard Pharmaceuticals Announces Commencement of Public Offering of Common Stock
(Business Wire)
01:06PM
Why Is Longboard Pharmaceuticals (LBPH) Stock Up 175% Today?
(InvestorPlace)
08:00AM
Longboard Pharmaceuticals Announces Positive Topline Data from the PACIFIC Study, a Phase 1b/2a Clinical Trial, for Bexicaserin (LP352) in Participants with Developmental and Epileptic Encephalopathies (DEEs)
(Business Wire)
Jan-01-24 04:47PM
Longboard Pharmaceuticals to Host Call to Discuss Topline Data from the PACIFIC Study, a Phase 1b/2a Clinical Trial for Bexicaserin (LP352) in Participants with Developmental and Epileptic Encephalopathies (DEEs)
(Business Wire)
Nov-29-23 08:30AM
Longboard Pharmaceuticals Announces Initiation of First-in-Human Phase 1 Clinical Study of LP659 in Adult Healthy Volunteers
(Business Wire)
Nov-24-23 09:35AM
Down -25.05% in 4 Weeks, Here's Why You Should You Buy the Dip in Longboard Pharmaceuticals, Inc. (LBPH)
(Zacks)
Nov-21-23 04:00PM
Longboard Pharmaceuticals Presence at American Epilepsy Society (AES) Annual Meeting Reinforces Ongoing Commitment to the Rare Epilepsy Community
(Business Wire)
Nov-14-23 05:05PM
FMR LLC Adjusts Stake in Longboard Pharmaceuticals Inc
(GuruFocus.com)
02:46PM Loading…
Nov-13-23 02:46PM
Farallon Capital: A Global and Diversified Hedge Fund and its Top Stock Picks
(Insider Monkey) -5.47%
Nov-08-23 09:55AM
Wall Street Analysts Believe Longboard Pharmaceuticals, Inc. (LBPH) Could Rally 262.45%: Here's is How to Trade
(Zacks)
Nov-03-23 04:01PM
Longboard Pharmaceuticals Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
(Business Wire)
Nov-02-23 07:16PM
Longboard Pharmaceuticals Inc (LBPH) Reports Q3 2023 Financial Results
(GuruFocus.com)
04:01PM
Longboard Pharmaceuticals Provides Corporate Update and Reports Third Quarter 2023 Financial Results
(Business Wire)
Nov-01-23 08:30AM
Longboard Pharmaceuticals to Present at Three Upcoming Investor Conferences in November
(Business Wire)
Oct-05-23 04:05PM
Longboard Pharmaceuticals Announces Speakers for Investor & Analyst Event in New York on October 11, 2023
(Business Wire) +9.61%
Sep-19-23 08:30AM
Longboard Pharmaceuticals to Host Investor & Analyst Event in New York on October 11, 2023
(Business Wire)
Aug-31-23 04:00PM
Longboard Pharmaceuticals to Participate in Three Upcoming Investor Conferences
(Business Wire)
Aug-30-23 04:01PM
Longboard Pharmaceuticals to Present Data at Upcoming Medical Meetings
(Business Wire) -6.65%
Aug-23-23 08:30AM
Longboard Pharmaceuticals Completes Enrollment of Phase 1b/2a PACIFIC Study Evaluating LP352 for the Treatment of Developmental and Epileptic Encephalopathies
(Business Wire)
Aug-10-23 08:49AM
Institutional investors own a significant stake of 39% in Longboard Pharmaceuticals, Inc. (NASDAQ:LBPH)
(Simply Wall St.)
Aug-03-23 04:01PM
Longboard Pharmaceuticals Provides Corporate Update and Reports Second Quarter 2023 Financial Results
(Business Wire)
08:30AM
Longboard Pharmaceuticals to Present at Upcoming Investor Conferences
(Business Wire)
Jun-26-23 04:00PM
Longboard Pharmaceuticals to Participate in Fireside Chat with Cantor on Friday, June 30, 2023
(Business Wire)
May-12-23 06:06AM
Will Longboard Pharmaceuticals (NASDAQ:LBPH) Spend Its Cash Wisely?
(Simply Wall St.) -11.74%
May-09-23 04:00PM
Longboard Pharmaceuticals Provides Corporate Update and Reports First Quarter 2023 Financial Results
(Business Wire)
May-01-23 08:50AM
Longboard Pharmaceuticals, Inc. (LBPH) is on the Move, Here's Why the Trend Could be Sustainable
(Zacks) -6.76%
Apr-14-23 08:50AM
Recent Price Trend in Longboard Pharmaceuticals, Inc. (LBPH) is Your Friend, Here's Why
(Zacks) +5.74%
Apr-11-23 04:00PM
Longboard Pharmaceuticals to Present at the 22nd Annual Needham Virtual Healthcare Conference
(Business Wire) +6.38%
Apr-07-23 09:55AM
Does Longboard Pharmaceuticals, Inc. (LBPH) Have the Potential to Rally 208.22% as Wall Street Analysts Expect?
(Zacks)
Apr-05-23 07:00AM
Societal CDMO Selected by Longboard Pharmaceuticals to Provide CDMO Services to Support Clinical Development of LP352
(GlobeNewswire)
Mar-07-23 09:55AM
Wall Street Analysts Predict an 184.81% Upside in Longboard Pharmaceuticals, Inc. (LBPH): Here's What You Should Know
(Zacks) -5.24%
Mar-06-23 09:48AM
Longboard Pharmaceuticals, Inc. (NASDAQ:LBPH) Q4 2022 Earnings Call Transcript
(Insider Monkey) +6.35%
Mar-02-23 04:01PM
Longboard Pharmaceuticals Reports Full Year 2022 Financial Results and Key Corporate Initiatives
(Business Wire)
Feb-23-23 04:31PM
Longboard Pharmaceuticals to Report Full Year 2022 Financial Results and Key Corporate Initiatives on March 2, 2023
(Business Wire)
Feb-10-23 04:01PM
Longboard Pharmaceuticals Announces Closing of Public Offering and Full Exercise of Underwriters Option to Purchase Additional Shares in Public Offering of Common Stock
(Business Wire)
Feb-07-23 09:03PM
Longboard Pharmaceuticals Announces Pricing of Public Offering of Common Stock
(Business Wire)
04:13PM
Longboard Pharmaceuticals Announces Commencement of Public Offering of Common Stock
(Business Wire)
Jan-14-23 08:00AM
Hedge funds investors have a lot riding on Longboard Pharmaceuticals, Inc. (NASDAQ:LBPH) with 27% ownership
(Simply Wall St.)
Dec-05-22 08:30AM
Longboard Pharmaceuticals Announces Positive Topline Data from a Phase 1 Clinical Study Evaluating Central Nervous System Pharmacokinetics and Pharmacodynamics of LP352 in Healthy Volunteers
(Business Wire) -8.57%
Nov-29-22 08:30AM
Longboard Pharmaceuticals Presence at American Epilepsy Society (AES) Annual Meeting Reinforces Ongoing Commitment to the Rare Epilepsy Community
(Business Wire)
Nov-08-22 08:30AM
Longboard Pharmaceuticals to Present at Guggenheims Healthcare Talks 4th Annual Immunology and Neurology Day
(Business Wire) +8.80%
Nov-03-22 08:30AM
Longboard Pharmaceuticals Provides Corporate Update and Reports Third Quarter 2022 Financial Results
(Business Wire) +8.47%
Oct-25-22 09:00AM
Is Longboard Pharmaceuticals (NASDAQ:LBPH) In A Good Position To Deliver On Growth Plans?
(Simply Wall St.)
Sep-29-22 04:01PM
Longboard Pharmaceuticals to Participate in the Cantor Neurology & Psychiatry Conference
(GlobeNewswire)
Sep-01-22 04:01PM
Longboard Pharmaceuticals to Participate in Upcoming Investor Conferences
(GlobeNewswire) +17.31%
Aug-04-22 04:05PM
Longboard Pharmaceuticals Provides Corporate Update and Reports Second Quarter 2022 Financial Results
(GlobeNewswire) +7.60%
Aug-03-22 08:30AM
Longboard Pharmaceuticals to Present at the 2022 Wedbush PacGrow Healthcare Virtual Conference
(GlobeNewswire)
Jun-07-22 08:30AM
Longboard Pharmaceuticals to Present at the JMP Securities 2022 Life Sciences Conference on June 15
(GlobeNewswire)
Jun-01-22 08:30AM
Longboard Pharmaceuticals to Participate in Five Upcoming Epilepsy-Focused Conferences this Summer
(GlobeNewswire)
May-18-22 07:07AM
Companies Like Longboard Pharmaceuticals (NASDAQ:LBPH) Are In A Position To Invest In Growth
(Simply Wall St.) -5.67%
May-12-22 08:30AM
Longboard Pharmaceuticals to Participate in Upcoming Investor Events
(GlobeNewswire)
May-05-22 04:05PM
Longboard Pharmaceuticals Provides Corporate Update and Reports First Quarter 2022 Financial Results
(GlobeNewswire)
Apr-01-22 08:30AM
Longboard Pharmaceuticals to Present Phase 1 Data for LP352 at the American Academy of Neurology Annual Meeting
(GlobeNewswire)
Mar-23-22 04:01PM
Longboard Pharmaceuticals to Participate in Cantor Fitzgeralds Virtual Rare Orphan Disease Summit
(GlobeNewswire) -6.90%
Mar-22-22 04:01PM
Longboard Pharmaceuticals to Participate in Maxim Group 2022 Virtual Growth Conference
(GlobeNewswire)
Mar-21-22 04:01PM
Longboard Pharmaceuticals Announces the Appointment of Highly Accomplished Healthcare Executive Randall Kaye, M.D., as Chief Medical Officer
(GlobeNewswire) +6.19%
Mar-03-22 04:05PM
Longboard Pharmaceuticals Provides Corporate Update and Reports Full Year 2021 Financial Results
(GlobeNewswire) -12.53%
Jan-05-22 08:30AM
Longboard Pharmaceuticals to Present at the H.C. Wainwright BioConnect Virtual Conference
(GlobeNewswire) -8.07%
Dec-09-21 07:52AM
We Think Longboard Pharmaceuticals (NASDAQ:LBPH) Can Afford To Drive Business Growth
(Simply Wall St.)
Dec-06-21 10:00AM
Longboard Pharmaceuticals, Inc. (LBPH) Could Find Support Soon, Here's Why You Should Buy the Stock Now
(Zacks) -9.33%
Nov-17-21 08:30AM
Longboard Pharmaceuticals Appoints Life Sciences Executive Dr. Jane Tiller to Board of Directors
(GlobeNewswire)
Nov-11-21 08:30AM
Longboard Pharmaceuticals to Participate in Upcoming Investor Conferences
(GlobeNewswire)
Nov-04-21 04:05PM
Longboard Pharmaceuticals Provides Corporate Update and Reports Third Quarter 2021 Financial Results
(GlobeNewswire) -5.56%
Nov-02-21 08:30AM
Longboard Pharmaceuticals Announces Steven W. Spector Joins the Company as General Counsel
(GlobeNewswire)
Sep-21-21 08:30AM
Longboard Pharmaceuticals to Present at the Cantor Virtual Global Healthcare Conference on September 28, 2021
(GlobeNewswire)
Sep-10-21 09:47AM
What You Need To Know About Longboard Pharmaceuticals, Inc.'s (NASDAQ:LBPH) Investor Composition
(Simply Wall St.)
Sep-08-21 07:00AM
Longboard Pharmaceuticals Successfully Completes LP352 Multiple Ascending Dose Portion of Phase 1 Clinical Trial in Healthy Volunteers, Plans to Initiate Phase 1b/2a Clinical Trial
(GlobeNewswire)
Aug-31-21 08:30AM
Longboard Pharmaceuticals to Present at Two Upcoming Investor Conferences
(GlobeNewswire) +5.51%
Aug-09-21 08:30AM
Longboard Pharmaceuticals Provides Corporate Update and Reports Second Quarter 2021 Financial Results
(GlobeNewswire)
Jun-12-21 05:58AM
We're Not Worried About Longboard Pharmaceuticals' (NASDAQ:LBPH) Cash Burn
(Simply Wall St.)
May-10-21 04:05PM
Longboard Pharmaceuticals Provides Corporate Update and Reports First Quarter 2021 Financial Results
(GlobeNewswire)
Mar-11-21 09:44PM
Longboard Pharmaceuticals Announces Pricing of Initial Public Offering
(GlobeNewswire)
Longboard Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which engages in the research and development of medicines for neurological diseases. The company was founded on January 3, 2020 and is headquartered in San Diego, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
ARENA PHARMACEUTICALS INCFormer 10% OwnerJan 25 '24Sale24.253,978,54096,479,5950Jan 29 04:37 PM
open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR
affiliate • advertise • toggle light mode • contact • privacy • help
do not sell my data • privacy settings
Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2024 FINVIZ.com. All Rights Reserved.